ResearcherUniversity of PardubiceActive in the last 2 years
Michal Holčapek
Matched on ORCID iD 0000-0003-3978-1249; OpenAlex author ID A5057012496. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 14
2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 4 papers
Papers 7
- Benzoyl chloride derivatization improves selectivity and sensitivity of lipidomic quantitation in human serum of pancreatic cancer patients using RP-UHPLC/MS/M… Last author DOI 10.1007/s00216-025-06151-0↗
- RP-UHPLC/MS/MS provides enhanced lipidomic profiling of human serum in pancreatic cancer. Last author DOI 10.1016/j.aca.2025.344952↗
- Resolving lipid isomers up to the double bond position level using reversed-phase chromatography, EAD fragmentation, and high-resolution mass spectrometry: App… Co-author DOI 10.1016/j.aca.2026.345225↗
- Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum. Last author DOI 10.1038/s43856-026-01445-5↗
- HILIC/MS quantitation of low-abundant phospholipids and sphingolipids in human plasma and serum: Dysregulation in pancreatic cancer. Last author DOI 10.1016/j.aca.2023.342144↗
- Comprehensive characterization of complex glycosphingolipids in human pancreatic cancer tissues. Last author DOI 10.1016/j.jbc.2023.102923↗
- Lipidomic profiling of human serum enables detection of pancreatic cancer. Last author DOI 10.1038/s41467-021-27765-9↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ondřej Peterka · 5 shared papers, 2022–2026 · strength 1.17
- Paper RP-UHPLC/MS/MS provides enhanced lipidomic profiling of human serum in pancreatic cancer. DOI 10.1016/j.aca.2025.344952↗
- Paper Benzoyl chloride derivatization improves selectivity and sensitivity of lipidomic quantitation in human serum of pancre… DOI 10.1007/s00216-025-06151-0↗
- Paper Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum. DOI 10.1038/s43856-026-01445-5↗
- Bohuslav Melichar · 5 shared papers, 2022–2026 · strength 1.13
- Paper RP-UHPLC/MS/MS provides enhanced lipidomic profiling of human serum in pancreatic cancer. DOI 10.1016/j.aca.2025.344952↗
- Paper Benzoyl chloride derivatization improves selectivity and sensitivity of lipidomic quantitation in human serum of pancre… DOI 10.1007/s00216-025-06151-0↗
- Paper Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum. DOI 10.1038/s43856-026-01445-5↗
- Zuzana Lásko · 4 shared papers, 2023–2026 · strength 1.01
- Paper RP-UHPLC/MS/MS provides enhanced lipidomic profiling of human serum in pancreatic cancer. DOI 10.1016/j.aca.2025.344952↗
- Paper Benzoyl chloride derivatization improves selectivity and sensitivity of lipidomic quantitation in human serum of pancre… DOI 10.1007/s00216-025-06151-0↗
- Paper HILIC/MS quantitation of low-abundant phospholipids and sphingolipids in human plasma and serum: Dysregulation in pancr… DOI 10.1016/j.aca.2023.342144↗
- Martin Loveček · 3 shared papers, 2026 · strength 0.83
- Paper RP-UHPLC/MS/MS provides enhanced lipidomic profiling of human serum in pancreatic cancer. DOI 10.1016/j.aca.2025.344952↗
- Paper Benzoyl chloride derivatization improves selectivity and sensitivity of lipidomic quantitation in human serum of pancre… DOI 10.1007/s00216-025-06151-0↗
- Paper Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum. DOI 10.1038/s43856-026-01445-5↗
- Beatrice Mohelníková-Duchoňová · 3 shared papers, 2026 · strength 0.83
- Paper RP-UHPLC/MS/MS provides enhanced lipidomic profiling of human serum in pancreatic cancer. DOI 10.1016/j.aca.2025.344952↗
- Paper Benzoyl chloride derivatization improves selectivity and sensitivity of lipidomic quantitation in human serum of pancre… DOI 10.1007/s00216-025-06151-0↗
- Paper Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum. DOI 10.1038/s43856-026-01445-5↗
- Milan Vošmik · 2 shared papers, 2026 · strength 0.54
- Petr Karásek · 2 shared papers, 2022–2026 · strength 0.35
- Denise Wolrab · 2 shared papers, 2022–2024 · strength 0.34
- Evelyn Rampler · 1 shared paper, 2026 · strength 0.30
- Marlene Pühringer · 1 shared paper, 2026 · strength 0.30
- Jan Trna · 1 shared paper, 2026 · strength 0.24
- Karel Hořejší · 1 shared paper, 2023 · strength 0.19
- Pavel Škrha · 1 shared paper, 2022 · strength 0.11
- Jan Škrha · 1 shared paper, 2022 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.